Skip to main content
. 2015 May;13(3):294–303. doi: 10.2174/1570159X13666150403231920

B. NGF Therapeutic Potential Based on Human Diseases

Disease Dose Treatment Side Effects Outcome Refs.
Neurotrophic keratitis 10μg* 4 weeks None Healed [54]
Immune cornea ulcer 10μg* 6-8 weeks None Healed [14]
Glaucoma 10μg* 12-15 weeks None Protective [15]
Maculopathy 10μg* 15-20 weeks None Protective [16]
Crush syndrome 10μg** 1 week None Protective [97]
Vasculitic ulcer 20μg** 20 weeks None Healed [63]
Pressure ulcer 20μg** 10 weeks None Healed [22]
Other
Diabetic neuropathy 0.3μg*** 3 weeks Local pain Protection? [9]